共 50 条
- [41] GS-441524 and molnupiravir are similarly effective for the treatment of cats with feline infectious peritonitisFRONTIERS IN VETERINARY SCIENCE, 2024, 11Sase, OkihiroIwami, TomokoSasaki, TakeruSano, Tadashi
- [42] Efficacy of Oral Remdesivir Compared to GS-441524 for Treatment of Cats with Naturally Occurring Effusive Feline Infectious Peritonitis: A Blinded, Non-Inferiority StudyVIRUSES-BASEL, 2023, 15 (08):Cosaro, EmmaPires, JullyCastillo, DiegoMurphy, Brian G.Reagan, Krystle L.
- [43] Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamstersFRONTIERS IN PHARMACOLOGY, 2022, 13Abdelnabi, RanaMaes, Pietde Jonghe, StevenWeynand, BirgitNeyts, Johan
- [44] An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in CatsVIRUSES-BASEL, 2022, 14 (11):Cook, SarahWittenburg, LukeYan, Victoria C.Theil, Jacob H.Castillo, DiegoReagan, Krystle L.Williams, SonyiaPham, Cong-DatLi, ChunMuller, Florian L.Murphy, Brian G.
- [45] Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster ModelMBIO, 2022, 13 (01):Chiba, ShihoKiso, MakiNakajima, NorikoIida, ShunMaemura, TadashiKuroda, MakotoSato, YukoIto, MutsumiOkuda, MoeYamada, ShinyaIwatsuki-Horimoto, KiyokoWatanabe, TokikoImai, MasakiArmbrust, TammyBaric, Ralph S.Halfmann, Peter J.Suzuki, TadakiKawaoka, Yoshihiro
- [46] Synthesis and anti-SARS-CoV-2 activity of deuterated GS-441524 analogsTETRAHEDRON LETTERS, 2022, 104Zheng, WeiHu, TianwenZhang, YuminWei, DaibaoXie, YuanchaoShen, Jingshan
- [47] Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020-2022)JOURNAL OF FELINE MEDICINE AND SURGERY, 2023, 25 (09)Taylor, Samantha S.Coggins, SallyBarker, Emi N.Gunn-Moore, DanielleJeevaratnam, KamalanNorris, Jacqueline M.Hughes, DavidStacey, EmilyMacfarlane, LauraO'Brien, CarolynKorman, RachelMclauchlan, GerardTorres, Xavier SalordTaylor, AimeeBongers, JosCastro, Laura EspadaForeman, MaxMcmurrough, JamesThomas, BethanyRoyaux, EmilieSaiz, Isabel CalvoBertoldi, GuidoHarlos, CarolineWork, MeganPrior, CameronSorrell, StephanieMalik, RichardTasker, Severine
- [48] In vitro antiviral effects of GS-441524 and itraconazole combination against feline infectious peritonitis virusRESEARCH IN VETERINARY SCIENCE, 2022, 144 : 27 - 33Doki, TomoyoshiTakahashi, KenHasegawa, NobuhisaTakano, Tomomi
- [49] Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 TreatmentFRONTIERS IN PHARMACOLOGY, 2022, 13Wang, Amy Q. Q.Hagen, Natalie R. R.Padilha, Elias C. C.Yang, MengbiShah, PranavChen, Catherine Z. Z.Huang, WenweiTerse, PramodSanderson, PhilipZheng, WeiXu, Xin
- [50] Validation of LC-MS/MS methods for determination of remdesivir and its metabolites GS-441524 and GS-704277 in acidified human plasma and their application in COVID-19 related clinical studiesANALYTICAL BIOCHEMISTRY, 2021, 617Xiao, DeqingLing, Kah Hiing JohnTarnowski, ThomasHumeniuk, RitaGerman, PolinaMathias, AnitaChu, JasperChen, Yuan-Shekvan Ingen, Eric